CareCloud, Inc. (CCLD)
NASDAQ: CCLD · Real-Time Price · USD
2.860
-0.150 (-4.98%)
Nov 4, 2025, 4:00 PM EST - Market closed
CareCloud Employees
CareCloud had 3,650 employees as of December 31, 2024. The number of employees increased by 50 or 1.39% compared to the previous year.
Employees
3,650
Change (1Y)
50
Growth (1Y)
1.39%
Revenue / Employee
$30,628
Profits / Employee
$5
Market Cap
121.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3,650 | 50 | 1.39% |
| Dec 31, 2023 | 3,600 | -550 | -13.25% |
| Dec 31, 2022 | 4,150 | 50 | 1.22% |
| Dec 31, 2021 | 4,100 | 400 | 10.81% |
| Dec 31, 2020 | 3,700 | 1,000 | 37.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CCLD News
- 15 days ago - CareCloud to Present at the 2025 ThinkEquity Conference - GlobeNewsWire
- 19 days ago - CareCloud 8.75% CUM RED PERP PFD SER B: Not Your Usual Preferred Shares - Seeking Alpha
- 20 days ago - CareCloud to Present at the 2025 Maxim Growth Summit - GlobeNewsWire
- 21 days ago - CareCloud to Announce Third Quarter 2025 Results on November 6, 2025 - GlobeNewsWire
- 4 weeks ago - CareCloud Announces Preferred Stock Dividend Payments - GlobeNewsWire
- 5 weeks ago - CareCloud Announces Acquisition of HFMA's MAP App to Expand AI-Driven Benchmarking in Hospitals and Integrated Health Systems - GlobeNewsWire
- 5 weeks ago - CareCloud Unveils Marketware as Strategic Growth Solution for Hospitals - GlobeNewsWire
- 7 weeks ago - CareCloud's Medsphere Acquisition: Why I Think It's A Buy - Seeking Alpha